Last update 23 Jan 2025

JNJ-90301900

Overview

Basic Info

Drug Type
Unknown
Synonyms
Target-
Mechanism-
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Locally Advanced Lung Non-Small Cell CarcinomaNon-small cell lung cancer stage III
Inactive Indication-
Originator Organization
Johnson & Johnson Enterprise Innovation, Inc.
Active Organization
Johnson & Johnson Enterprise Innovation, Inc.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JNJ-90301900
NCT06667908
/ RecruitingPhase 2
A Phase 2, Randomized, Open-Label, Active-Controlled Study of JNJ-90301900 in Combination With Chemoradiation Followed by Durvalumab in Locally Advanced and Unresectable Stage III NSCLC
100 Clinical Results associated with JNJ-90301900
Login to view more data
100 Translational Medicine associated with JNJ-90301900
Login to view more data
100 Patents (Medical) associated with JNJ-90301900
Login to view more data
100 Deals associated with JNJ-90301900
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Lung Non-Small Cell CarcinomaPhase 2
US
Johnson & Johnson Enterprise Innovation, Inc.
06 Dec 2024
Non-small cell lung cancer stage IIIPhase 2
US
Johnson & Johnson Enterprise Innovation, Inc.
06 Dec 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free